Related Experiment Video
Updated: Jun 23, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Reduced platelet BDNF level in patients with major depression
1Department of Psychiatry, College of Medicine, Korea University Ansan Hospital, Republic of Korea.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|April 18, 2009
Summary
Platelet brain-derived neurotrophic factor (BDNF) levels are significantly lower in patients with major depressive disorder (MDD). This finding suggests reduced platelet BDNF may be linked to lower serum BDNF in depression.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Decreased serum, plasma, and brain brain-derived neurotrophic factor (BDNF) levels are observed in major depressive disorder (MDD).
- Platelets store significant amounts of BDNF, acting as a circulating reservoir.
Purpose of the Study:
- To investigate whether platelet BDNF levels are reduced in patients with MDD compared to healthy controls.
- To explore potential differences in platelet BDNF between non-suicidal and recent-suicidal MDD patients.
Main Methods:
- BDNF levels were measured in platelet-rich plasma (PRP) and platelet-poor plasma (PPP) from 20 non-suicidal MDD patients, 20 recent-suicidal MDD patients, and 20 healthy controls.
- Platelet BDNF content was calculated and standardized per million platelets.
- Participants were assessed using the Structured Clinical Interview for DSM-IV and the Hamilton Depression Rating Scale.
Main Results:
- Platelet BDNF content was significantly lower in both non-suicidal (3.09±2.53 pg/10^6 platelets) and recent-suicidal (3.16±1.99 pg/10^6 platelets) MDD patients compared to healthy controls (6.17±2.64 pg/10^6 platelets) (p<0.01).
- No significant difference in platelet BDNF content was found between non-suicidal and recent-suicidal MDD groups.
- PRP BDNF levels were lower in MDD patients than controls (p=0.029), while PPP BDNF levels showed no significant difference between groups (p=0.971).
Conclusions:
- Platelet BDNF content is significantly reduced in patients with major depressive disorder.
- Reduced platelet BDNF may contribute to lower circulating BDNF levels observed in MDD.
- Platelet BDNF serves as a potential biomarker for major depressive disorder.
Related Concept Videos
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...